Testing effectiveness (Phase 2)Study completedNCT01309230What this trial is testingA Trial of FANG™ Vaccine for Participants With Ovarian CancerWho this might be right forOvarian Cancer Gradalis, Inc. 39
Early research (Phase 1)Study completedNCT03304210What this trial is testingPIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian CancerWho this might be right forPeritoneal CarcinomatosisOvarian Cancer Stage IIIBOvarian Cancer Stage IIIC+8 more University Hospital, Ghent 20
Testing effectiveness (Phase 2)Study completedNCT02766582What this trial is testingPhase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary CancerWho this might be right forOvarian Cancer Medical College of Wisconsin 29
Early research (Phase 1)Study completedNCT00089362What this trial is testingAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsWho this might be right forMale Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00003944What this trial is testingCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer Fox Chase Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00795769What this trial is testingOndansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+101 more Fred Hutchinson Cancer Center 49
Testing effectiveness (Phase 2)Looking for participantsNCT05564377What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialWho this might be right forAdvanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+12 more National Cancer Institute (NCI) 2,900
Testing effectiveness (Phase 2)Active Not RecruitingNCT04550494What this trial is testingMeasuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate Carcinoma+28 more National Cancer Institute (NCI) 29
Not applicableStudy completedNCT05025748What this trial is testingAsk Questions (ASQ):Implementation of a Communication InterventionWho this might be right forStage II Breast CancerStage III Breast CancerStage IV Breast Cancer+20 more Barbara Ann Karmanos Cancer Institute 81
Early research (Phase 1)Study completedNCT00003704What this trial is testingChemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerWho this might be right forCancer Alliance for Clinical Trials in Oncology 51
Large-scale testing (Phase 3)Active Not RecruitingNCT04095364What this trial is testingLetrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forLow Grade Fallopian Tube Serous AdenocarcinomaOvarian Low Grade Serous AdenocarcinomaPrimary Peritoneal Low Grade Serous Adenocarcinoma+9 more NRG Oncology 450
Testing effectiveness (Phase 2)Study completedNCT00072267What this trial is testingUCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer University Health Network, Toronto
Not applicableWithdrawnNCT04985357What this trial is testingDefining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWho this might be right forStage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more Travera Inc
Early research (Phase 1)Study completedNCT03784677What this trial is testingA Phase I Study of SOR-C13 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmRefractory Ovarian Carcinoma+20 more M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)UnknownNCT00003634What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and ChemotherapyWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer AltaRex 400
Testing effectiveness (Phase 2)Study completedNCT02122185What this trial is testingMetformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forBrenner TumorMalignant AscitesMalignant Pleural Effusion+25 more University of Chicago 111
Not applicableStudy completedNCT00897442What this trial is testingCollecting Tumor Samples From Patients With Gynecological TumorsWho this might be right forBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Study completedNCT00314678What this trial is testingCisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal CancerWho this might be right forEpithelial Ovarian CancerPrimary Peritoneal Cancer John P. Fruehauf 40
Not applicableStudy completedNCT01096394What this trial is testingCollection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial CancerWho this might be right forOvarian Cancer Vanderbilt University 20
Early research (Phase 1)Ended earlyNCT02933073What this trial is testingStudy of Oncoimmunome for the Treatment of Stage III/IV Ovarian CarcinomaWho this might be right forOvarian Cancer UConn Health 8